Cargando…
Select-agent status could slow development of anti-SARS therapies
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096004/ https://www.ncbi.nlm.nih.gov/pubmed/23223045 http://dx.doi.org/10.1038/nm1212-1722 |
_version_ | 1783510731286642688 |
---|---|
author | Matthews, Susan |
author_facet | Matthews, Susan |
author_sort | Matthews, Susan |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7096004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Nature Publishing Group US |
record_format | MEDLINE/PubMed |
spelling | pubmed-70960042020-03-26 Select-agent status could slow development of anti-SARS therapies Matthews, Susan Nat Med Article Nature Publishing Group US 2012-12-06 2012 /pmc/articles/PMC7096004/ /pubmed/23223045 http://dx.doi.org/10.1038/nm1212-1722 Text en © Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2012 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Matthews, Susan Select-agent status could slow development of anti-SARS therapies |
title | Select-agent status could slow development of anti-SARS therapies |
title_full | Select-agent status could slow development of anti-SARS therapies |
title_fullStr | Select-agent status could slow development of anti-SARS therapies |
title_full_unstemmed | Select-agent status could slow development of anti-SARS therapies |
title_short | Select-agent status could slow development of anti-SARS therapies |
title_sort | select-agent status could slow development of anti-sars therapies |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7096004/ https://www.ncbi.nlm.nih.gov/pubmed/23223045 http://dx.doi.org/10.1038/nm1212-1722 |
work_keys_str_mv | AT matthewssusan selectagentstatuscouldslowdevelopmentofantisarstherapies |